Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00419536
What this trial is testing

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

Who this might be right for
Hormone Refractory Prostate Cancer Disease
Novartis Pharmaceuticals 108
Testing effectiveness (Phase 2)Ended earlyNCT01545882
What this trial is testing

A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Ottawa Hospital Research Institute 5
Testing effectiveness (Phase 2)Study completedNCT00004327
What this trial is testing

Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEctasia
National Center for Research Resources (NCRR) 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955082
What this trial is testing

The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment

Who this might be right for
Hormone Refractory Prostate Cancer
Institute of Cancer Research, United Kingdom 305
Large-scale testing (Phase 3)Study completedNCT00417079
What this trial is testing

XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
NeoplasmsProstatic Neoplasms
Sanofi 755
Testing effectiveness (Phase 2)Study completedNCT00466440
What this trial is testing

Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Eli Lilly and Company 108
Testing effectiveness (Phase 2)Ended earlyNCT01093183
What this trial is testing

Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer
University of Nebraska 25
Testing effectiveness (Phase 2)Study completedNCT00673127
What this trial is testing

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 57
Early research (Phase 1)Looking for participantsNCT07705334
What this trial is testing

SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsTriple Negative Breast Cancer (TNBC)HR+ Breast Cancer+8 more
SHY Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00003614
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT00448734
What this trial is testing

Picoplatin and Docetaxel in Subjects With Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Poniard Pharmaceuticals 95
Testing effectiveness (Phase 2)Study completedNCT00537381
What this trial is testing

An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Centocor, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT00473512
What this trial is testing

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Who this might be right for
Prostatic Neoplasms
Cougar Biotechnology, Inc. 54
Testing effectiveness (Phase 2)Study completedNCT00337077
What this trial is testing

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-refractory Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 121
Testing effectiveness (Phase 2)Study completedNCT00001446
What this trial is testing

Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasm
National Cancer Institute (NCI) 64
Early research (Phase 1)Study completedNCT01664728
What this trial is testing

An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 54
Large-scale testing (Phase 3)Ended earlyNCT00089856
What this trial is testing

GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 626
Testing effectiveness (Phase 2)UnknownNCT00003183
What this trial is testing

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Hope Cancer Institute, Inc. 64
Early research (Phase 1)Study completedNCT02182219
What this trial is testing

Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Study completedNCT00087165
What this trial is testing

GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 22
Next Page